Largest health care companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 170 health care companies ranked by earnings, at ZAR 463.6B, ahead of Eli Lilly (ZAR 357B) and Merck & Co (ZAR 315.7B). Figures as of 19 Nov 2026, 14:21 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- Johnson & JohnsonZAR 463.6B
- Median
- ZAR 4.7B
- Combined market value
- ZAR 157.31T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Hims & Hers HealthHIMS · Health Care | ZAR 2.2B | ZAR 69.1B | ZAR 294.89 | 2.85% down | 49% down | ||
| 102 | Ligand PharmaceuticalsLGND · Health Care | ZAR 2.2B | ZAR 103.3B | ZAR 5,166.45 | 1.67% up | 50% up | ||
| 103 | Corcept TherapeuticsCORT · Health Care | ZAR 1.7B | ZAR 128.3B | ZAR 1,172.49 | 3.25% down | 10% down | ||
| 104 | HaemoneticsHAE · Health Care | ZAR 1.7B | ZAR 96.8B | ZAR 2,124.97 | 1.60% up | 64% up | ||
| 105 | Amneal PharmaceuticalsAMRX · Health Care | ZAR 1.2B | ZAR 131.9B | ZAR 378.43 | 3.60% up | 90% up | ||
| 106 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | ZAR 1B | ZAR 129.2B | ZAR 1,643.97 | 0.06% down | 129% up | ||
| 107 | RepligenRGEN · Health Care | ZAR 845.7M | ZAR 190.9B | ZAR 2,986.48 | 6.47% up | 12% up | ||
| 108 | LifeStance Health GroupLFST · Health Care | ZAR 167.1M | ZAR 90.5B | ZAR 238.16 | 2.82% down | 123% up | ||
| 109 | BillionToOneBLLN · Health Care | ZAR 128.9M | ZAR 75.6B | ZAR 1,583.26 | 6.11% down | 4% down | ||
| 110 | Arrowhead PharmaceuticalsARWR · Health Care | -ZAR 28.2M | ZAR 105.4B | ZAR 745.62 | 0.28% up | 13% up | ||
| 111 | BrukerBRKR · Health Care | -ZAR 148.7M | ZAR 167.1B | ZAR 1,094.14 | 3.10% up | 44% up | ||
| 112 | RadNetRDNT · Health Care | -ZAR 322.6M | ZAR 97.9B | ZAR 1,242.19 | 4.14% down | 9% down | ||
| 113 | Mirum PharmaceuticalsMIRM · Health Care | -ZAR 404.1M | ZAR 104.4B | ZAR 1,599.69 | 0.59% up | 34% up | ||
| 114 | Travere TherapeuticsTVTX · Health Care | -ZAR 441.8M | ZAR 83.4B | ZAR 868.94 | 1.68% down | 45% up | ||
| 115 | 10x GenomicsTXG · Health Care | -ZAR 753.1M | ZAR 129.8B | ZAR 987.07 | 1.37% up | 247% up | ||
| 116 | Adaptive BiotechnologiesADPT · Health Care | -ZAR 1B | ZAR 79.7B | ZAR 492.24 | 0.11% down | 74% up | ||
| 117 | Caris Life SciencesCAI · Health Care | -ZAR 1.2B | ZAR 96.7B | ZAR 337.27 | 2.21% down | 19% down | ||
| 118 | VeradermicsMANE · Health Care | -ZAR 1.2B | ZAR 91.1B | ZAR 2,159.56 | 0.62% down | 231% up | ||
| 119 | Belite BioBLTE · Health Care | -ZAR 1.3B | ZAR 109.7B | ZAR 2,702.13 | 0.94% down | 43% up | ||
| 120 | Twist BioscienceTWST · Health Care | -ZAR 1.3B | ZAR 137.2B | ZAR 2,012.37 | 3.88% up | 346% up | ||
| 121 | Oruka TherapeuticsORKA · Health Care | -ZAR 1.8B | ZAR 112.3B | ZAR 1,655.91 | 0.60% down | 255% up | ||
| 122 | HeartflowHTFL · Health Care | -ZAR 2B | ZAR 69.8B | ZAR 793.71 | 2.51% down | 66% up | ||
| 123 | ErascaERAS · Health Care | -ZAR 2.2B | ZAR 83.5B | ZAR 237.99 | 0.94% down | 395% up | ||
| 124 | Protagonist TherapeuticsPTGX · Health Care | -ZAR 2.3B | ZAR 143.6B | ZAR 2,199.34 | 2.00% up | 51% up | ||
| 125 | Charles River Laboratories InternationalCRL · Health Care | -ZAR 2.5B | ZAR 276.2B | ZAR 5,763.85 | 0.33% up | 106% up | ||
| 126 | Spyre TherapeuticsSYRE · Health Care | -ZAR 2.7B | ZAR 166.7B | ZAR 1,754.84 | 8.15% up | 332% up | ||
| 127 | CG OncologyCGON · Health Care | -ZAR 2.8B | ZAR 123.6B | ZAR 1,383.67 | 1.34% up | 97% up | ||
| 128 | Dianthus TherapeuticsDNTH · Health Care | -ZAR 2.8B | ZAR 81.8B | ZAR 1,452.51 | 3.45% down | 108% up | ||
| 129 | Edgewise TherapeuticsEWTX · Health Care | -ZAR 2.9B | ZAR 78.3B | ZAR 715.53 | 1.59% down | 86% up | ||
| 130 | Axsome TherapeuticsAXSM · Health Care | -ZAR 3.2B | ZAR 121.9B | ZAR 2,317.65 | 1.43% down | 6% down | ||
| 131 | Definium TherapeuticsDFTX · Health Care | -ZAR 3.2B | ZAR 69B | ZAR 503.66 | 0.88% down | 168% up | ||
| 132 | GlaukosGKOS · Health Care | -ZAR 3.2B | ZAR 238.6B | ZAR 4,031.32 | 4.18% down | 145% up | ||
| 133 | Rhythm PharmaceuticalsRYTM · Health Care | -ZAR 3.4B | ZAR 142.7B | ZAR 2,058.90 | 2.08% up | 18% up | ||
| 134 | NateraNTRA · Health Care | -ZAR 3.6B | ZAR 726.1B | ZAR 5,007.15 | 0.71% up | 28% up | ||
| 135 | Kodiak SciencesKOD · Health Care | -ZAR 4B | ZAR 110.6B | ZAR 1,691.71 | 1.04% up | 399% up | ||
| 136 | Elanco Animal HealthELAN · Health Care | -ZAR 4B | ZAR 230.8B | ZAR 461.80 | 3.29% up | 26% up | ||
| 137 | LivaNovaLIVN · Health Care | -ZAR 4.2B | ZAR 90.1B | ZAR 1,635.15 | 2.85% up | 77% up | ||
| 138 | Ascendis PharmaASND · Health Care | -ZAR 4.4B | ZAR 306.7B | ZAR 4,675.59 | 0.32% down | 29% up | ||
| 139 | Madrigal PharmaceuticalsMDGL · Health Care | -ZAR 5B | ZAR 159.9B | ZAR 6,885.14 | 5.67% down | 27% down | ||
| 140 | Legend BiotechLEGN · Health Care | -ZAR 5.1B | ZAR 54.5B | ZAR 281.06 | 0.87% up | 41% down | ||
| 141 | Roivant SciencesROIV · Health Care | -ZAR 5.2B | ZAR 485.4B | ZAR 669.87 | 0.05% up | 91% up | ||
| 142 | Praxis Precision MedicinesPRAX · Health Care | -ZAR 5.2B | ZAR 147.5B | ZAR 5,278.52 | 0.04% up | 86% up | ||
| 143 | Kymera TherapeuticsKYMR · Health Care | -ZAR 5.4B | ZAR 178.9B | ZAR 2,095.05 | 0.32% down | 87% up | ||
| 144 | Cogent BiosciencesCOGT · Health Care | -ZAR 5.7B | ZAR 83.7B | ZAR 481.00 | 0.14% down | 20% down | ||
| 145 | MiniMed GroupMMED · Health Care | -ZAR 5.8B | ZAR 82.7B | ZAR 293.86 | 4.44% down | 8% down | ||
| 146 | ImmunityBioIBRX · Health Care | -ZAR 6.1B | ZAR 123.3B | ZAR 115.88 | 7.03% up | 232% up | ||
| 147 | Jazz PharmaceuticalsJAZZ · Health Care | -ZAR 6.2B | ZAR 275.1B | ZAR 4,285.40 | 2.93% up | 41% up | ||
| 148 | Bausch + LombBLCO · Health Care | -ZAR 6.2B | ZAR 129.5B | ZAR 362.35 | 0.58% up | 44% up | ||
| 149 | ABIVAXABVX · Health Care | -ZAR 6.4B | ZAR 126.9B | ZAR 1,449.91 | 2.11% up | 32% down | ||
| 150 | Scholar Rock HoldingSRRK · Health Care | -ZAR 6.5B | ZAR 101.3B | ZAR 830.20 | 6.48% up | 26% up | ||
| 151 | Ionis PharmaceuticalsIONS · Health Care | -ZAR 6.6B | ZAR 78.9B | ZAR 473.73 | 1.59% up | 63% down | ||
| 152 | GRAILGRAL · Health Care | -ZAR 7.1B | ZAR 79.4B | ZAR 1,765.91 | 3.57% down | 19% up | ||
| 153 | Guardant HealthGH · Health Care | -ZAR 7.2B | ZAR 339.6B | ZAR 2,510.32 | 1.30% up | 45% up | ||
| 154 | Oscar HealthOSCR · Health Care | -ZAR 7.7B | ZAR 148.1B | ZAR 476.85 | 7.61% down | 112% up | ||
| 155 | ImmunovantIMVT · Health Care | -ZAR 8.7B | ZAR 118.7B | ZAR 573.70 | 0.12% down | 46% up | ||
| 156 | AvantorAVTR · Health Care | -ZAR 9.2B | ZAR 180.1B | ZAR 265.84 | 1.25% up | 40% up | ||
| 157 | CRISPR TherapeuticsCRSP · Health Care | -ZAR 10.1B | ZAR 67.4B | ZAR 695.12 | 0.10% up | 18% down | ||
| 158 | BridgeBio PharmaBBIO · Health Care | -ZAR 12.7B | ZAR 262.8B | ZAR 1,349.25 | 1.58% up | 21% up | ||
| 159 | VaxcytePCVX · Health Care | -ZAR 13.3B | ZAR 160.2B | ZAR 1,012.15 | 1.48% down | 23% up | ||
| 160 | CytokineticsCYTK · Health Care | -ZAR 13.6B | ZAR 123.6B | ZAR 887.62 | 0.64% down | 19% down | ||
| 161 | TeleflexTFX · Health Care | -ZAR 15.7B | ZAR 113.8B | ZAR 2,868.52 | 3.95% up | 58% up | ||
| 162 | Takeda PharmaceuticalTAK · Health Care | -ZAR 16.5B | ZAR 1.18T | ZAR 367.88 | 1.71% down | 51% up | ||
| 163 | Baxter InternationalBAX · Health Care | -ZAR 16.6B | ZAR 234.1B | ZAR 452.46 | 1.55% up | 50% up | ||
| 164 | Summit TherapeuticsSMMT · Health Care | -ZAR 18.7B | ZAR 145.2B | ZAR 181.61 | 1.59% down | 36% down | ||
| 165 | Revolution MedicinesRVMD · Health Care | -ZAR 19.6B | ZAR 597.9B | ZAR 2,764.22 | 1.76% down | 129% up | ||
| 166 | BioNTechBNTX · Health Care | -ZAR 21.8B | ZAR 357B | ZAR 1,440.05 | 1.89% down | 14% down | ||
| 167 | InsmedINSM · Health Care | -ZAR 22.1B | ZAR 454.6B | ZAR 2,072.04 | 1.69% down | 40% down | ||
| 168 | ModernaMRNA · Health Care | -ZAR 48.8B | ZAR 1.38T | ZAR 3,403.65 | 4.84% down | 780% up | ||
| 169 | ViatrisVTRS · Health Care | -ZAR 60.8B | ZAR 402.1B | ZAR 350.76 | 0.83% down | 99% up | ||
| 170 | CenteneCNC · Health Care | -ZAR 115.4B | ZAR 577.5B | ZAR 1,166.61 | 7.03% down | 94% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2959 ZAR).
Questions and answers
Which health care companies rank first by earnings?
Johnson & Johnson (ZAR 463.6B), Eli Lilly (ZAR 357B) and Merck & Co (ZAR 315.7B) are the top three of the 170 health care companies ranked by earnings as of 19 Nov 2026, 14:21 UTC.
How many health care companies are in this ranking?
170 are ranked by earnings.
What are these health care companies worth together?
The 170 health care companies ranked by earnings have a combined market value of ZAR 157.31T as of 19 Nov 2026, 14:21 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care companies by earnings”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.